(Press-News.org) A novel drug is showing promise for alleviating heart failure, a common condition associated with sleep apnoea and a reduced lifespan.
The drug, known as AF-130, was tested in an animal model at Waipapa Taumata Rau, the University of Auckland where researchers found it improved the heart’s ability to pump, but, equally important, prevented sleep apnoea, which itself reduces lifespan (see Nature Communications). “This drug does offer benefit for heart failure, but it’s two for the price of one, in that it’s also relieving the apnoea for which there is currently no drug, only CPAP (a breathing device), which is poorly tolerated,” says Professor Julian Paton, director of the University’s Manaaki Manawa, Centre for Heart Research.
When a person has a heart attack and subsequent heart failure, the brain responds by activating the sympathetic system, the ‘fight or flight’ response, as a way to stimulate the heart to pump blood. However, the brain persists with this activation of the nervous system, even when it is no longer required, and this together with the consequent sleep apnoea, contributes to the patient’s reduced life expectancy. Most patients die within five years of a heart failure diagnosis.
“This study has revealed the first drug to temper the nervous activity from the brain to the heart thereby reversing the heart’s progressive decline in heart failure,” says Professor Paton.
The part of the brain that sends nervous impulses to the heart is also controlling respiration, so this drug has a dual function, reducing the ‘fight or flight’ response while also stimulating breathing to stop the sleep apnoea. “These findings have real potential for improving the wellness and life expectancy of almost 200,000 people living with heart disease in Aotearoa New Zealand,” says Professor Paton.
Another exciting factor for the scientists, who are from the University of Auckland and the University of São Paulo, Brazil, is that the drug is soon to be FDA approved, albeit for a different health issue, paving the way for human trials in the next year or two, Professor Paton says.
“Over recent decades there have been several classes of drugs that have improved the prognosis of heart failure,” says cardiology consultant and Associate Professor, Martin Stiles. "However, none of these drugs work in the way that this new agent does. So it is exciting to see a novel method that potentially reverses some features of heart failure."
END
Novel drug offers hope for heart failure patients
A novel drug is showing promise for alleviating both heart failure and the sleep apnoea associated with it.
2023-03-30
ELSE PRESS RELEASES FROM THIS DATE:
Symbiotic yeast helps longicorn beetles eat wood
2023-03-30
Even for insects, wood is a tough food source as it contains hard substances such as cellulose. To help make wood more palatable, some wood-feeding insects are assisted by symbiotic microorganisms that break down the components of wood into an edible form. A group from Nagoya University in Japan has isolated a symbiotic yeast from adults, larvae, and eggs of the Japanese longicorn beetle and identified specialized organs that store the yeast, allowing the beetles to break down the unpalatable components of wood. Their findings were published in PLOS ONE.
“I have been fascinated with longicorn beetles ...
Environment: Honeybees provide a snapshot of city landscape and health
2023-03-30
Urban honeybees could be used to gain insight into the microbiome of the cities in which they forage, which can potentially provide information on both hive and human health, reports a study published in Environmental Microbiome.
Cities are built for human habitation but are also spaces that host a wide range of living species, and understanding this diverse landscape is important for urban planning and human health. However, sampling the microbial landscape in a manner to cover wide areas of a city can be labour-intensive.
Elizabeth ...
First successful simulations of how various shapes of galaxies are formed
2023-03-30
The standard cosmology can answer almost nothing about how the structure of a galaxy is formed. It expects a supermassive black hole at the center and dark matter in the halo to explain the circulation of stars and its velocity. However, why the visible matters are distributed in such a thin plane by the interaction with the black hole while dark matter results in a spherical distribution is a critical open question for a disc galaxy. The formation process of elliptical, ring, and long–barred galaxies also remains unknown.
The Energy Circulation ...
Can a solid be a superfluid? Engineering a novel supersolid state from layered 2D materials
2023-03-30
A collaboration of Australian and European physicists predict that layered electronic 2D semiconductors can host a curious quantum phase of matter called the supersolid.
The supersolid is a very counterintuitive phase indeed. It is made up of particles that simultaneously form a rigid crystal and yet at the same time flow without friction since all the particles belong to the same single quantum state.
A solid becomes ‘super’ when its quantum properties match the well-known quantum properties of superconductors. A supersolid simultaneously has two orders, solid and super:
solid because of the spatially repeating pattern ...
ASU associate professor wins Fulbright Award to study sexual-assault prevention
2023-03-30
Throughout her career, Arizona State University Edson College of Nursing and Health Innovation Associate Professor Kelly Davis has worked to translate her research into action. An expert in alcohol-involved sexual assault, Davis’ studies have been cited in U.S. legislation and have earned her a MERIT Award and now the prestigious Fulbright Scholar Award.
The program will take her to the United Kingdom beginning in early 2024 to collaborate with colleagues at the University ...
New RNA-based toolkit to regulate gene activity could advance regenerative medicine, gene therapy and biotechnology
2023-03-30
The Okinawa Institute of Science and Technology (OIST), in collaboration with Astellas Pharma Inc., has developed a new toolkit that uses small molecules to control the activity of a piece of synthetic RNA, and ultimately regulate gene expression. The technology, which was described in the Journal of the American Chemical Society on March 30, 2023, worked in mammalian cell cultures and in mice.
The ability to precisely control whether a gene is turned on or off is expected to lead to more efficient production of compounds that are made using animal cells, and make gene therapy, cell therapy, and regenerative medicine safer.
For genes to be expressed, cells make many RNA copies of a section ...
Babies’ gut microbiome not influenced by mothers’ vaginal microbiome composition
2023-03-30
It has been a longstanding assumption that birth mode and associated exposure of newborns to their mothers’ vaginal microbiome during delivery greatly affects the development of babies’ gut microbiome.
To test the scientific validity of this assumption, a team of Canadian researchers has now published a study in Frontiers in Cellular and Infection Microbiology in which they examined the effect of maternal vaginal microbiome composition on the development of infants’ stool microbiome at 10 days and three months after birth.
“We show that ...
2023 Canada Gairdner Awards recognize world-renowned scientists for transformative contributions to research impacting human health
2023-03-30
The Gairdner Foundation is pleased to announce the 2023 Canada Gairdner Award laureates, recognizing some of the world’s most significant biomedical and global health research and discoveries.
“Congratulations to all the 2023 Canada Gairdner Award recipients! The ground-breaking work of this year’s laureates has resulted in innovative, globally accessible tools to fight diseases and improve our well-being. The work of two Canadian researchers – Dr. Christopher Mushquash and Dr. Gelareh Zadeh especially ...
Researchers use tiny diamonds to create intracellular sensors
2023-03-30
Researchers use tiny diamonds to create intracellular sensors
Optically trapped nanodiamonds could be used to measure temperature, magnetic fields and other properties inside living cells
VANCOUVER -- Researchers have developed a new way to study the intricate dynamics within living cells by using optically trapped nanodiamond particles as intracellular sensors. Using custom built optical tweezers, the research team trapped the particles within the cell at low power while the cell was alive. The work represents an important advancement in quantum sensing, which takes advantage of quantum mechanics to analyze changes at the atomic level.
The researchers used optical tweezers ...
New study identifies key risk factors for surgical site infection following commonly performed surgery
2023-03-30
Arlington, Va., March 30, 2023 – Findings from an analysis of more than 66,000 abdominal hysterectomies performed in New York hospitals reveal key risk factors for surgical site infections (SSIs) following these procedures, including open surgery, obesity, diabetes, gynecological cancer, and age under 45. Published today in the American Journal of Infection Control (AJIC), the data can help inform surgical and clinical decisions to reduce post-operative infections.
“Improved understanding of patient-related, clinical, and surgical factors ...
LAST 30 PRESS RELEASES:
High Mountain Asia’s shrinking glaciers linked to monsoon changes
All DRII-ed up: How do plants recover after drought?
Research on stigma says to just ‘shake it off’
Scientists track lightning “pollution” in real time using NASA satellite
Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy
Hot days make for icy weather, Philippine study finds
Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology
World's first clinical trial showing lubiprostone aids kidney function
Capturing language change through the genes
Public trust in elections increases with clear facts
Thawing permafrost raised carbon dioxide levels after the last ice age
New DNA test reveals plants’ hidden climate role
Retinitis pigmentosa mouse models reflect pathobiology of human RP59
Cell’s ‘antenna’ could be key to curing diseases
Tiny ocean partnership between algae and bacteria reveals secrets of evolution
Scientists uncover cellular “toolkit” to reprogram immune cells for cancer therapy
Blocking protein control pathway slows rhabdomyosarcoma growth in mice
2026 Hertz Fellowship Application Now Open
The gut immune system is altered in mouse model of Alzheimer’s, providing a new target for therapeutics
ADHD drugs are being prescribed too quickly to preschoolers
UCLA scientists develop off-the-shelf immunotherapy for metastatic kidney cancer
Extreme heat linked to spike in domestic violence calls in New Orleans, study finds
Mount Sinai-Duke University study identifies DNA variants that increase testosterone production in PCOS patients
Physiology-guided complete revascularization in older patients with myocardial infarction
Metals and sulfate in air pollution mixture may contribute most to asthma hospitalizations
Understanding the profound yet hidden effects of neglect on white matter structures
SEOULTECH researchers develop revolutionary 3D-printed smart materials create high-performance pressure sensors for wearables
Pusan National University scientists develop self-deploying material for next-gen robotics
Remote screening for asymptomatic atrial fibrillation
Inflammation may explain why women with no standard modifiable risk factors have heart attacks and strokes
[Press-News.org] Novel drug offers hope for heart failure patientsA novel drug is showing promise for alleviating both heart failure and the sleep apnoea associated with it.